Hydroquinone in Skincare
Hydroquinone is a well-supported prescription treatment for facial melasma. In the U.S., hydroquinone skin-lightening products are not approved for OTC sale, and the exact prescription, duration, follow-up, and sun protection all matter.
- Aliases
- 1,4-Benzenediol, Benzene-1,4-diol, Quinol
- Ingredient category
- Brightening Ingredient
- Most relevant for
- Hyperpigmentation
- Evidence strength
- Well Supported for Improving facial melasma with topical prescription hydroquinone formulations
- Formula matters
- Concentration, combination ingredients, vehicle, stability, storage, treatment duration, irritation, and sun protection shape results. Tri-Luma trial results do not automatically apply to hydroquinone alone or compounded formulas.
- Separate product needed?
- Yes, for a specific purpose. A separate hydroquinone prescription is appropriate when a clinician has identified melasma or another pigment condition that justifies targeted treatment.
BB takeaway
Hydroquinone is one of the better-supported melasma treatments, but it belongs in a defined prescription plan rather than routine brightening skincare. Diagnosis, stopping rules, follow-up, and sun protection matter as much as percentage.
Ingredient evidence does not prove the performance of every finished product containing it.
What is hydroquinone?
Hydroquinone is a depigmenting medicine used to reduce excess melanin in treated skin. It is also known as 1,4-benzenediol, benzene-1,4-diol, and quinol.[1]
Dermatologists commonly use hydroquinone in treatment plans for melasma and may use it for other diagnosed forms of hyperpigmentation.
In the United States, hydroquinone skin-lightening products are not approved for over-the-counter sale. FDA states that prescription skin products containing hydroquinone remain available through healthcare providers.[2]
Prescription does not automatically mean FDA-approved. Tri-Luma has an approved New Drug Application; other hydroquinone prescriptions may be compounded or otherwise not FDA-approved as finished drug products.
What does hydroquinone do for skin?
Hydroquinone reduces the production of new melanin in the treated area. As pigmented surface cells turn over, excess pigmentation can gradually look lighter and more even.
Its strongest established use is melasma. It may also be used in clinician-directed plans for other forms of hyperpigmentation when the diagnosis supports it.
Hydroquinone does not remove the trigger that keeps pigmentation active. UV exposure, visible light, hormones, acne, friction, and irritation can continue to stimulate pigment during treatment.
It also does not erase indented scars, treat active acne, remove vascular redness, or permanently prevent melasma from returning.
What the evidence says about hydroquinone skincare
Hydroquinone is well supported for improving facial melasma with topical treatment.
A 2023 systematic review and meta-analysis of topical melasma therapies included 45 efficacy studies with 2,359 patients. Hydroquinone monotherapy and hydroquinone-containing combination therapy both produced substantial reductions in melasma severity, although several non-hydroquinone treatments also performed well.[3]
A separate 2023 review of 174 randomized or controlled melasma trials gave the triple-combination cream a Grade A recommendation but rated hydroquinone 4% cream Grade B in its treatment table.[4]
The clearest FDA-reviewed finished-product evidence belongs to Tri-Luma, a prescription cream containing 4% hydroquinone, 0.05% tretinoin, and 0.01% fluocinolone acetonide. It is approved for short-term treatment of moderate-to-severe facial melasma with sun-avoidance measures.[5]
Tri-Luma performed better in its pivotal trials than creams containing only two of its three active ingredients.[5] That evidence belongs to the complete triple-combination product and should not be transferred automatically to hydroquinone alone or to a compounded formula.
Tri-Luma’s trials studied adults with Fitzpatrick skin types I–IV; safety and effectiveness in types V and VI were not studied. The product is not approved for melasma maintenance.
Hydroquinone works, but it is not universally superior to every alternative. Comparative reviews show that agents such as azelaic acid, tranexamic acid, cysteamine, and kojic acid can also improve melasma, with choice depending on tolerance, availability, and the treatment plan.[3]
One other evidence-backed approach is Thiamidol, a cosmetic brightening ingredient with controlled human pigmentation data. Evidence for an individual Thiamidol formula does not replace a diagnosis or automatically establish equivalence to a prescription hydroquinone regimen.
For a broader comparison of hydroquinone, Thiamidol, other cosmetic brighteners, and newer technology such as PNar, read Which Dark-Spot Ingredients Actually Work?. That comparison does not make cosmetic skincare interchangeable with a supervised prescription regimen.
How hydroquinone form and formulation affect results
Hydroquinone alone and a triple-combination prescription are not interchangeable treatments.
Adding tretinoin and a corticosteroid can improve results, but it also changes irritation risk, pregnancy considerations, storage, and how the product should be used.
Concentration is not a quality score. A higher percentage does not guarantee a better result and may increase irritation. Follow the concentration and schedule chosen for the diagnosed condition rather than shopping for the biggest number.
Vehicle, stability, storage, treatment area, duration, and the rest of the routine also matter. Hydroquinone formulas can oxidize and darken, so follow the pharmacy or manufacturer storage directions and ask about a major change in color, odor, or texture.
Scrubs, peels, exfoliating acids, extra retinoids, and several pigment treatments layered together can inflame the skin and make hyperpigmentation harder to control.
Who may benefit from hydroquinone skincare?
Hydroquinone makes the most sense when a clinician has diagnosed persistent melasma or another pigment condition where prescription treatment is appropriate.
It is less proportionate as the first response to one recent post-blemish mark or mild uneven tone. Depending on the concern, sunscreen, acne control, or ingredients such as azelaic acid, niacinamide, tranexamic acid, or vitamin C may be reasonable lower-intensity options.
A diagnosis matters because melasma, post-inflammatory hyperpigmentation, sun spots, medication-related discoloration, and other pigment changes can look similar while needing different management.
If you are pregnant, planning pregnancy, or breastfeeding, discuss the exact prescription with the clinician managing your care. Tri-Luma contains tretinoin and carries pregnancy-related warnings.[5]
Hydroquinone side effects and irritation risk
Hydroquinone can cause redness, stinging, burning, itching, dryness, peeling, or contact dermatitis. Combination formulas can add irritation from a retinoid, corticosteroid, or other active ingredients.
A rare but serious complication is exogenous ochronosis, which can cause blue-black or gray-blue darkening of treated skin. FDA continues to warn about rashes, facial swelling, and permanent skin discoloration reported with hydroquinone-containing skin-lightening products.[2]
Stop treatment and contact the prescriber if you notice unusual darkening, severe burning, swelling, blistering, or a worsening rash.
Do not treat persistent irritation as evidence that the medicine is working. Repeated inflammation can make pigmentation worse.
How to use hydroquinone in your skincare routine
Use hydroquinone exactly as prescribed. The application area, amount, frequency, duration, and stopping point depend on the exact formula and condition being treated.
Keep the supporting routine simple. A gentle cleanser, a comfortable moisturizer, the prescribed treatment, and daily sunscreen are usually more useful than layering several brightening products.
Tri-Luma is labeled for a thin once-nightly application to affected facial areas, at least 30 minutes before bedtime. Other hydroquinone prescriptions can have different directions.[5]
For melasma, use broad-spectrum sunscreen every day. Dermatologist guidance also recommends visible-light protection with a tinted sunscreen containing iron oxides because visible light can worsen melasma.[6]
How long does hydroquinone take to work?
Hydroquinone does not fade pigment overnight.
In the Tri-Luma trials, some improvement was seen by four weeks and the primary assessment was at eight weeks.[5]
That is not a universal timeline for every hydroquinone prescription. Melasma treatment often takes months, and recurrence is common.
Do not keep extending treatment indefinitely because results are slow. If improvement is limited or pigment returns quickly, the diagnosis, formula, maintenance plan, or ongoing triggers may need to be reassessed.
What can you use with hydroquinone?
Sunscreen is the essential partner. A plain moisturizer can also make treatment easier to tolerate.
Clinicians may combine hydroquinone with tretinoin, corticosteroids, chemical peels, or other pigment treatments. These combinations should be planned rather than assembled casually at home.
Other pigment-focused ingredients such as azelaic acid, tranexamic acid, kojic acid, vitamin C, or niacinamide may be used instead of or alongside hydroquinone depending on the treatment plan. They are not automatically interchangeable.
The main practical limit is irritation. A crowded routine can undermine pigment treatment by creating more inflammation.
How to choose a hydroquinone product
In the United States, do not shop for hydroquinone as an ordinary over-the-counter brightening product.
New cosmetic brighteners are a different category. BB’s Debut PNar launch report explains why a newly promoted pigmentation mechanism and company-reported early study figures should not be mistaken for a clinically established replacement for prescription treatment.
FDA currently states that hydroquinone skin-lightening products are not approved for OTC sale and warns consumers about illegal products containing hydroquinone or mercury sold through retail and online channels.[7]
Use a legitimate prescriber and pharmacy, and ask exactly what you are receiving. FDA continues to identify Tri-Luma as the only FDA-approved drug containing hydroquinone.[8]
A compounded or other prescription hydroquinone product can still be clinically appropriate, but it should not be described as having the same FDA-reviewed finished-product approval as Tri-Luma.
Confirm the concentration, full formula, treatment area, intended duration, storage instructions, and stopping rules before you begin.
Hydroquinone alone does not justify Premium pricing. The value comes from a correct diagnosis, legitimate dispensing, an appropriate formula, clear follow-up, and a workable sun-protection plan.
Do you need a separate hydroquinone product?
Yes, for a specific purpose.
A hydroquinone prescription makes sense when a clinician has identified melasma or another pigment problem that justifies targeted treatment.
It is not a routine brightening step for every dark mark. If discoloration is mild, recent, or linked to ongoing acne or irritation, controlling the trigger and using sunscreen consistently may be the higher-value first move.
The BB Perspective
Hydroquinone is one of the better-supported treatments for melasma, which is exactly why it should be treated like a medicine rather than a casual brightening ingredient.
The most important U.S. shopping distinction is regulatory: hydroquinone skin-lightening products are not approved for OTC sale, while prescription hydroquinone remains available. Tri-Luma is FDA-approved; other prescription or compounded hydroquinone products should not automatically inherit its approval or finished-product evidence.
Use hydroquinone when the diagnosis and treatment plan justify it. The prescription, stopping plan, follow-up, and sun protection are all part of what makes the treatment useful.
Last reviewed: September 2026
Sources
National Library of Medicine PubChem. Hydroquinone.
PubChem identifies hydroquinone as benzene-1,4-diol and lists 1,4-benzenediol and quinol among recognized names. This supports ingredient identity rather than treatment efficacy. Return to citation.
U.S. Food and Drug Administration. Skin Product Safety. Current September 2026.
FDA states that hydroquinone skin-lightening products are not approved for over-the-counter sale and that prescription products remain available through healthcare providers. It also reports serious adverse effects including rashes, facial swelling, and permanent discoloration called ochronosis. Return to citation.
Chang YF, Lee TL, Oyerinde O, et al. Efficacy and safety of topical agents in the treatment of melasma: What’s evidence? A systematic review and meta-analysis. Journal of Cosmetic Dermatology. 2023;22(4):1168-1176. doi:10.1111/jocd.15566. PMID:36566490.
This meta-analysis included 45 efficacy studies with 2,359 patients. Hydroquinone monotherapy and hydroquinone-containing combination therapy both produced substantial reductions in melasma severity, while several non-hydroquinone options also showed meaningful efficacy. The results support hydroquinone’s melasma role without establishing it as universally superior for every patient. The pooled trials varied substantially in design and outcomes, limiting direct comparisons. The paper lists its conflicts-of-interest statement as “Not applicable” and does not identify a funding source. Return to citation.
Sarkar R, Handog EB, Das A, et al. Topical and Systemic Therapies in Melasma: A Systematic Review. Indian Dermatology Online Journal. 2023;14(6):769-781. doi:10.4103/idoj.idoj_490_22. PMID:38099013. PMCID:PMC10718129.
The review included 174 randomized or controlled trials. Its treatment table gives Grade A to triple-combination cream and Grade B to hydroquinone 4% cream, although its abstract and conclusion broadly group both under Grade A. The authors reported no financial support or conflicts of interest. Return to citation.
DailyMed. Tri-Luma — fluocinolone acetonide, hydroquinone, and tretinoin cream prescribing information. Effective October 24, 2024.
The FDA-approved label identifies Tri-Luma as a prescription combination containing 0.01% fluocinolone acetonide, 4% hydroquinone, and 0.05% tretinoin for short-term treatment of moderate-to-severe facial melasma with sun avoidance. It also covers dosing, clinical-trial results, storage, pregnancy warnings, irritation, and ochronosis. Tri-Luma’s pivotal trials enrolled 641 adults with Fitzpatrick skin types I–IV; types V and VI were not studied. The label states that Tri-Luma is not for maintenance treatment. Galderma markets this FDA-approved, three-ingredient prescription product. Return to citation.
American Academy of Dermatology. Melasma: Self-care.
This dermatologist-reviewed guidance emphasizes broad-spectrum sunscreen and visible-light protection for melasma and recommends tinted sunscreen containing iron oxides. It also advises avoiding irritating skincare because irritation can darken melasma. Return to citation.
U.S. Food and Drug Administration. FDA Warns Consumers of Skin Products Containing Mercury and/or Hydroquinone. Current September 2026.
FDA states that there are no FDA-approved or legally marketed OTC skin-lightening products containing hydroquinone and documents illegal skin-lightening products identified through FDA testing. This supports avoiding unverified marketplace and retail hydroquinone products. Return to citation.
FDA identifies Tri-Luma as the only FDA-approved drug containing hydroquinone and explains why OTC hydroquinone skin-lightening products cannot be legally marketed without an approved application. This distinction should not be transferred to other prescription or compounded hydroquinone preparations. Return to citation.